Paul Langerhans Medal
The German Diabetes Society (DDG) has been awarding the Paul Langerhans Medal, named after the physician Paul Langerhans , since 1972 as an award for the life's work of scientists and doctors in the field of diabetology .
| year | Medal holder | Subject of the Paul Langerhans lecture |
|---|---|---|
| 1972 | Rolf Luft , Stockholm, Sweden | The Pathogenesis of Diabetes Mellitus in Man |
| 1973 | EF Pfeiffer, Ulm | Diabetes mellitus 1973. The open problems of theory and practice |
| 1974 | W. Creutzfeld , Göttingen | The islets of Langerhans and the gastrointestinal endocrine system |
| 1975 | K. Oberdisse, Düsseldorf | The development of diabetes research between Banting / Best and Yalow / Berson |
| 1976 | K. Schöffling, Frankfurt / Main | The four pillars of diabetes therapy |
| 1977 | W. Gepts, Brussels, Belgium | New perspectives in the pathology of the pancreas in diabetes mellitus |
| 1978 | ER Froesch, Zurich, Switzerland | Studies on insulin-like growth factors |
| 1979 | H. Zahn, Aachen | The chemical synthesis of insulin today |
| 1980 | PA Bastenie, Brussels, Belgium | Critical overview of the autoimmune processes in endocrinopathies, especially in diabetes mellitus |
| 1981 | K. Jahnke, Wuppertal | Diabetogenic food factors |
| 1982 | Z. Laron, Tel Aviv, Israel | Psychosocial Aspects in Children and Adolescents |
| 1983 | O. Wieland, Munich | Effect of insulin on phosphorylatable enzyme systems |
| 1984 | H. Mehnert, Munich | Ways and goals of diabetes therapy |
| 1985 | T. Deckert, Gentofte, Denmark | Malignant vasculopathies in insulin-dependent diabetes |
| 1986 | H. Sauer, Bad Oeynhausen | Insulin therapy. Review and current status |
| 1987 | A. Ullrich , San Francisco, USA | Molecular biological studies on insulin effects |
| 1988 | FA Gries, Düsseldorf | From the causes to the long-term consequences. Findings and perspectives in diabetes research |
| 1989 | K. Federlin, Giessen | Diabetic therapy through transplantation of islets of Langerhans. solved and unsolved problems |
| 1990 | CB Wollheim, Geneva, Switzerland | From signal transmission to exocytosis: how nutrients and neurohormones influence insulin secretion in β-cells |
| 1991 | D. Lohmann, Leipzig | The connection of morphological and functional methods in diabetes research |
| 1992 | PJ Lefebvre, Liege, Belgium | Glucagon, 123 years after Paul Langerhans |
| 1993 | D. Brandenburg, Aachen | From insulin to receptor, chemical ways to answer biological questions |
| 1994 | O. Panzram, Erfurt | Chronopathology of type 2 diabetes from an epidemiological point of view |
| 1995 | HP Meißner, Berlin | The membrane potential of the beta cells: What role does it play in regulating insulin secretion? |
| 1996 | FM Matschinsky, Philadelphia, PA. United States | The physiological and pathological chemistry of the pancreatic beta cell |
| 1997 | B. Weber, Berlin | Diabetes mellitus in children: a permanent challenge for doctors and society |
| 1998 | W. Waldhäusl, Vienna, Austria | Diabetes therapy: basics and concepts of new developments |
| 1999 | H. Schatz , Bochum | Langerhans island: regulation of the biosynthesis and secretion of insulin |
| 2000 | W. Berger, Basel, Switzerland | Ways to optimized insulin therapy for type 1 diabetes |
| 2001 | U. Panten, Braunschweig | Mechanisms of insulin secretion stimulated by glucose and sulfonylureas |
| 2002 | JJ Holst, Denmark | Regulation of the endocrine pancreas by intestinal hormones |
| 2003 | E. Ritz, Heidelberg | Pathogenesis and Clinic of Diabetic Nephropathy |
| 2004 | P. Hürter, Hanover | The Path of Pediatric Diabetology Past and Future |
| 2005 | S. Raptis, Athens, Greece | Diabetes therapy on the wrong track? |
| 2006 | R. Landgraf, Munich | Quality management in diabetology |
| 2007 | M. Hanefeld, Dresden | Near-normal postprandial hyperglycemia - an essential component of good diabetes control and prevention of cardiovascular disease |
| 2008 | H.-U. Haring, Tübingen | Pathogenesis of type 2 diabetes mellitus. Insulin resistance and genotype-phenotype characterization of type 2 diabetes |
| 2009 | RG Bretzel | Islet Cell Transplantation - A Prototype of Translational Research |
| 2010 | Hans-Georg Joost, Potsdam | From Mice and Humans - The Complex Pathogenetics of Type 2 Diabetes |
| 2011 | Sigurd Lenzen, Hanover | The beta cell of the islet of Langerhans at the center of type 1 pathogenesis |
| 2012 | Michael A. Nauck, Bad Lauterberg | Glucagon like peptides 1: 25 years of incentive in diabetes research |
| 2013 | Henning Beck-Nielsen, Odense, Denmark | Tailored treatment of type 2 diabetes based on present pathophysiology |
| 2014 | Matthias von Herrath, La Jolla, USA | Pathogenesis and prevention of type 1 diabetes |
| 2015 | Juleen Rae Zierath, Stockholm, Sweden | Muscling in on Insulin Resistance to Prevent Type 2 |
| 2016 | Emmanuel Van Obberghen, Nice, France | Novel insights in dysregulations of insulin action and secretion: relevance for type 2 diabetes |
| 2017 | Michael Roden, Düsseldorf | Insulin Resistance: A New Energy Crisis? |
| 2018 | Jens Claus Brüning , Cologne | CNS-dependent control of glucose homeostasis |
| 2019 | Matthias H. Tschöp , Munich | Poly-agonists for type 2 diabetes: discovery, mechanisms, and clinical efficacy |
Web links
- ↑ DIABETES CONGRESS 2019 (PDF; 4.7 MB); accessed on May 5, 2019.